ProNAi Therapeutics Company Profile (NASDAQ:DNAI)

About ProNAi Therapeutics

ProNAi Therapeutics logoProNAi Therapeutics, Inc. is a clinical-stage oncology company. The Company is engaged in business of researching, developing and commercializing therapies for the treatment of patients with cancer and hematological diseases based on its deoxyribonucleic acid interference (DNAi) technology platform. Its lead product candidate includes PNT2258, which targets cancers that overexpress B-cell lymphoma 2 (BCL2), an oncogene known to be dysregulated in various types of cancer. The Company's PNT2258 is a formulation of its single-stranded 24-base DNAi oligonucleotide, known as PNT100, encapsulated in the SMARTICLES Lipid Nanoparticle (LNP). The Company's PNT2258 consists of over two components, including PNT100 DNAi Oligonucleotide and LNP Delivery Technology. It has conducted over two clinical trials for PNT2258, which include a Phase I safety trial in patients with relapsed or refractory solid tumors and a Phase II trial in patients with relapsed or refractory non-Hodgkin's lymphoma (NHL).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: DNAI
  • CUSIP:
Key Metrics:
  • Previous Close: $1.86
  • 50 Day Moving Average: $1.97
  • 200 Day Moving Average: $4.37
  • 52-Week Range: $1.81 - $32.99
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.69
  • P/E Growth: -0.02
  • Market Cap: $56.40M
  • Outstanding Shares: 30,325,000
Additional Links:
Companies Related to ProNAi Therapeutics:

Analyst Ratings

Consensus Ratings for ProNAi Therapeutics (NASDAQ:DNAI) (?)
Ratings Breakdown: 3 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $14.83 (697.49% upside)

Analysts' Ratings History for ProNAi Therapeutics (NASDAQ:DNAI)
Show:
DateFirmActionRatingPrice TargetDetails
6/6/2016WedbushDowngradeOutperform -> NeutralView Rating Details
6/6/2016SunTrust Banks Inc.DowngradeBuy -> Neutral$25.00 -> $4.00View Rating Details
6/6/2016Jefferies GroupDowngradeBuy -> Hold$22.00 -> $4.50View Rating Details
8/10/2015Bank of America Corp.Initiated CoverageBuy$35.00View Rating Details
(Data available from 8/30/2014 forward)

Earnings

Earnings History for ProNAi Therapeutics (NASDAQ:DNAI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/12/2016Q216($0.38)($0.43)ViewN/AView Earnings Details
5/10/2016Q1($0.42)($0.35)ViewN/AView Earnings Details
3/3/2016Q415($0.58)($0.38)ViewN/AView Earnings Details
11/5/2015Q315($0.48)($11.03)ViewN/AView Earnings Details
8/21/2015Q215($104.10)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for ProNAi Therapeutics (NASDAQ:DNAI)
Current Year EPS Consensus Estimate: $-1.32 EPS
Next Year EPS Consensus Estimate: $-1.10 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.54)($0.39)($0.44)
Q2 20163($0.41)($0.37)($0.38)
Q3 20163($0.33)($0.31)($0.32)
Q4 20163($0.31)($0.23)($0.27)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for ProNAi Therapeutics (NASDAQ:DNAI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ProNAi Therapeutics (NASDAQ:DNAI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/22/2016Wendy ChapmanSVPSell3,000$7.01$21,030.00View SEC Filing  
2/22/2016Wendy ChapmanSVPSell3,000$7.06$21,180.00View SEC Filing  
1/22/2016Wendi RodiguezainsiderSell3,000$9.86$29,580.00View SEC Filing  
1/22/2016Wendy ChapmanSVPSell5,000$9.39$46,950.00View SEC Filing  
1/15/2016Nicholas GloverCEOSell5,000$10.04$50,200.00View SEC Filing  
1/12/2016Chandra D. LovejoySVPSell20,973$11.29$236,785.17View SEC Filing  
7/21/2015Orbimed Advisors LlcDirectorBuy175,000$17.00$2,975,000.00View SEC Filing  
7/21/2015Vivo Ventures Vii, LlcInsiderBuy220,000$17.00$3,740,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for ProNAi Therapeutics (NASDAQ:DNAI)
DateHeadline
benzinga.com logo(NEOS), ProNAi Therapeutcis, Inc. (NASDAQ:DNAI) - Stocks Hitting ... - Benzinga (NASDAQ:DNAI)
www.benzinga.com - August 29 at 8:48 PM
News IconStock on Trader's Radar: ProNAi Therapeutics, Inc. (NASDAQ:DNAI), YY Inc. (NASDAQ:YY) - Newburg Press (NASDAQ:DNAI)
newburghpress.com - August 23 at 4:46 PM
finance.yahoo.com logoPRONAI THERAPEUTICS INC Financials (NASDAQ:DNAI)
finance.yahoo.com - August 20 at 4:37 PM
News IconProNAi Therapeutics (DNAI) Stock: Here's What You Need To Know - CNA Finance (press release) (NASDAQ:DNAI)
cnafinance.com - August 16 at 4:42 PM
News IconProNAi Therapeutics Inc (NASDAQ:DNAI) to Report Quarterly ... - Post Registrar (NASDAQ:DNAI)
postregistrar.com - August 14 at 9:22 AM
finance.yahoo.com logo7:09 am ProNAi Therapeutics reports Q2 results (NASDAQ:DNAI)
finance.yahoo.com - August 13 at 4:37 PM
finance.yahoo.com logoProNAi Therapeutics Reports Second Quarter 2016 Results (NASDAQ:DNAI)
finance.yahoo.com - August 12 at 4:41 PM
sg.finance.yahoo.com logoProNAi Therapeutics reports 2Q loss (NASDAQ:DNAI)
sg.finance.yahoo.com - August 12 at 8:32 AM
biz.yahoo.com logoPRONAI THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E (NASDAQ:DNAI)
biz.yahoo.com - August 12 at 8:32 AM
News IconStock Update on ProNAi Therapeutics, Inc. (NASDAQ:DNAI) - Duncan Research (NASDAQ:DNAI)
www.duncanindependent.com - August 11 at 10:29 PM
streetupdates.com logoAnalysts Actions to Track: ProNAi Therapeutics, Inc. (NASDAQ:DNAI) , Edwards Lifesciences Corporation (NYSE:EW) - Street Updates (NASDAQ:DNAI)
www.streetupdates.com - August 4 at 4:53 PM
nasdaq.com logoProNAi Therapeutics (DNAI) is Oversold: Can It Recover? - Nasdaq (NASDAQ:DNAI)
www.nasdaq.com - July 29 at 11:40 AM
finance.yahoo.com logoProNAi Therapeutics (DNAI) is Oversold: Can It Recover? (NASDAQ:DNAI)
finance.yahoo.com - July 29 at 9:52 AM
fortune.com logoNoticeable Runners in Pre-Market: Twitter Inc. (NYSE:TWTR ... - Review Fortune (NASDAQ:DNAI)
reviewfortune.com - July 27 at 4:47 PM
News IconAre Analysts Bearish ProNAi Therapeutics Inc (NASDAQ:DNAI) After Last Week? - Consumer Eagle (NASDAQ:DNAI)
www.consumereagle.com - July 23 at 8:46 AM
News IconProNAi Therapeutics Inc (NASDAQ:DNAI): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:DNAI)
www.engelwooddaily.com - July 21 at 10:07 PM
News IconEarnings Focus and Crowd Sourced Sentiment Review for ProNAi Therapeutics Inc (NASDAQ:DNAI) - TGP (NASDAQ:DNAI)
telanaganapress.com - July 20 at 9:16 AM
News IconEquity Roundup: Stock Performance Focus on ProNAi Therapeutics Inc (NASDAQ:DNAI) - Press Telegraph (NASDAQ:DNAI)
presstelegraph.com - July 20 at 9:16 AM
fiscalstandard.com logoBroker Outlook For ProNAi Therapeutics, Inc. (DNAI) - Fiscal Standard (NASDAQ:DNAI)
www.fiscalstandard.com - July 20 at 9:16 AM
streetupdates.com logoAnalysts Suggestion Alert: ProNAi Therapeutics, Inc. (NASDAQ:DNAI) , Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) - Street Updates (NASDAQ:DNAI)
www.streetupdates.com - July 19 at 10:47 AM
News IconProNAi Therapeutics Inc (NASDAQ:DNAI)'s Company Shares Decreased 2.43% After Low Volatility - Consumer Eagle (NASDAQ:DNAI)
www.consumereagle.com - July 18 at 4:47 PM
fiscalstandard.com logoProNAi Therapeutics, Inc. (DNAI) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:DNAI)
www.fiscalstandard.com - July 17 at 9:10 AM
news.cmlviz.com logoProNAi Therapeutics Inc Stock Momentum Hits Extreme Weakness - CML News (NASDAQ:DNAI)
news.cmlviz.com - July 16 at 4:32 PM
ftsenews.co.uk logoNew Broker Ratings For ProNAi Therapeutics, Inc. (DNAI) - FTSE News (NASDAQ:DNAI)
www.ftsenews.co.uk - July 15 at 3:39 PM
News IconPronai Therapeutics Incorporated (NASDAQ:DNAI) Shorted Shares Increased 9.52% After Market Selling - Press Telegraph (NASDAQ:DNAI)
presstelegraph.com - July 15 at 8:00 AM
News IconWere Analysts Bearish ProNAi Therapeutics Inc (NASDAQ:DNAI) This Week? - Consumer Eagle (NASDAQ:DNAI)
www.consumereagle.com - July 15 at 8:00 AM
News IconAnalyst Target and Average Rating Watch: ProNAi Therapeutics Inc (NASDAQ:DNAI) - Press Telegraph (NASDAQ:DNAI)
presstelegraph.com - July 14 at 6:19 AM
News IconProNAi Therapeutics Inc (NASDAQ:DNAI) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:DNAI)
telanaganapress.com - July 13 at 9:35 AM
News IconPronai Therapeutics Incorporated (NASDAQ:DNAI) Shorted Shares Increased By 9.52% - Engelwood Daily (NASDAQ:DNAI)
www.engelwooddaily.com - July 10 at 9:10 AM
News IconCompany Stock Focus for ProNAi Therapeutics Inc (NASDAQ:DNAI): Which Way Will Shares Head? - Press Telegraph (NASDAQ:DNAI)
presstelegraph.com - July 7 at 9:51 PM
fiscalstandard.com logoProNAi Therapeutics, Inc. (DNAI) Current Analyst Ratings - Fiscal Standard (NASDAQ:DNAI)
www.fiscalstandard.com - July 6 at 4:43 PM
ftsenews.co.uk logoProNAi Therapeutics, Inc. (DNAI) Updated Price Targets - FTSE News (NASDAQ:DNAI)
www.ftsenews.co.uk - July 5 at 9:25 AM
fiscalstandard.com logoRecently Issued Stock Ratings For ProNAi Therapeutics, Inc. (DNAI) - Fiscal Standard (NASDAQ:DNAI)
www.fiscalstandard.com - June 30 at 4:52 PM
fiscalstandard.com logoBroker Outlook For The Week Ahead ProNAi Therapeutics, Inc. (DNAI) - Fiscal Standard (NASDAQ:DNAI)
www.fiscalstandard.com - June 28 at 4:35 PM
News IconPronai Therapeutics Incorporated (NASDAQ:DNAI) Short Interest Increased By 9.52% - Press Telegraph (NASDAQ:DNAI)
presstelegraph.com - June 26 at 4:16 PM
tradecalls.org logoPrice Target Update on ProNAi Therapeutics (NASDAQ:DNAI) - Trade Calls (NASDAQ:DNAI)
www.tradecalls.org - June 24 at 11:24 AM
News IconProNAi Therapeutics Inc (NASDAQ:DNAI) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:DNAI)
www.engelwooddaily.com - June 23 at 9:39 PM
News IconInvestor News: Investigation of ProNAi Therapeutics Inc (NASDAQ:DNAI) over potential Violations of Securities Laws - GroundReport (NASDAQ:DNAI)
www.groundreport.com - June 23 at 3:34 PM
News IconProNAi Therapeutics (NASDAQ:DNAI) Analyst Rating Consensus - TheFounders Daily (NASDAQ:DNAI)
www.thefoundersdaily.com - June 22 at 4:47 PM
News IconInvestor News: Investigation of ProNAi Therapeutics Inc (NASDAQ:DNAI) over potential Violations of Securities Laws (NASDAQ:DNAI)
www.groundreport.com - June 22 at 9:20 AM
4-traders.com logoPRONAI THERAPEUTICS INC : Submission of Matters to a Vote of Security Holders (form 8-K) (NASDAQ:DNAI)
www.4-traders.com - June 21 at 4:28 PM
biz.yahoo.com logoPRONAI THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:DNAI)
biz.yahoo.com - June 21 at 4:17 PM
fiscalstandard.com logoThis Weeks Broker Views For ProNAi Therapeutics, Inc. (DNAI) - Fiscal Standard (NASDAQ:DNAI)
www.fiscalstandard.com - June 20 at 10:53 AM
istreetwire.com logoLatest ProNAi Therapeutics, Inc. (NASDAQ:DNAI) Target Price Suggests Stock Is Worth $11.63/Share - iStreetWire (NASDAQ:DNAI)
istreetwire.com - June 17 at 9:55 AM
News IconAnalyst Recommendations: Liberty Ventures (NASDAQ:LVNTA), ProNAi Therapeutics, Inc. (NASDAQ:DNAI) - Beacon Chronicle (NASDAQ:DNAI)
www.beaconchronicle.com - June 17 at 9:55 AM
streetupdates.com logoTwo Movers inside Analysts Radar: GLOBAL BLOOD THERAPEUTICS, INC. (NASDAQ:GBT) , ProNAi Therapeutics ... - Street Updates (NASDAQ:DNAI)
www.streetupdates.com - June 15 at 4:44 PM
News IconAnalyst Recommended Stocks: Duke Realty Corporation (NYSE:DRE), ProNAi Therapeutics, Inc. (NASDAQ:DNAI) - Beacon Chronicle (NASDAQ:DNAI)
www.beaconchronicle.com - June 15 at 4:44 PM
News IconStock's Earnings Analysis: ProNAi Therapeutics, Inc. (NASDAQ:DNAI), Prospect Capital Corporation (NASDAQ:PSEC) - Beacon Chronicle (NASDAQ:DNAI)
www.beaconchronicle.com - June 15 at 4:44 PM
News IconInvestor Investigation of ProNAi Therapeutics Inc (NASDAQ:DNAI) over Possible Violations of Securities Laws (NASDAQ:DNAI)
www.ssuchronicle.com - June 14 at 4:31 PM
kcregister.com logoBiotech New Lows: ProNAi Therapeutics, Inc. (NASDAQ:DNAI), Chimerix, Inc. (NASDAQ:CMRX), ImmunoGen, Inc ... - KC Register (NASDAQ:DNAI)
www.kcregister.com - June 13 at 9:42 AM

Social

ProNAi Therapeutics (NASDAQ:DNAI) Chart for Tuesday, August, 30, 2016


Last Updated on 8/30/2016 by MarketBeat.com Staff